| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |